This announcement is a separate document:
桂林三金：2024年一季度报告
Guilin Sanjin Pharmaceutical: 2024 First Quarter Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated